// App-Quantinova.ai

1144-189 : THE COMPARATIVE SAFETY OF BIVALIRUDIN VERSUS HEPARIN MONOTHERAPY IN PATIENTS ON DIALYSIS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM

Researchers

Presenter

  • Devraj Sukul

Principal Investigators

  • Milan Seth

  • Theodore Schreiber

  • George Hanzel

  • Akshay Khandelwal

  • Louis Cannon

  • Thomas LaLonde

  • Ronald Miller

  • Hitinder Gurm

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • Bivalirudin

  • Heparin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim